Save your place

Sign in to WhoBought

Please try again later.

Phathom Pharmaceuticals, Inc. (PHAT) institutional ownership

Latest close $11.25 Jul 21, 2026
Market cap$583M 52-week range SectorHealthcare
Funds holding · Q1 2026
179
reported PHAT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
105 buyers · 74 sellers

Phathom Pharmaceuticals, Inc. (PHAT) price and institutional activity

Dates

Q1 2026

$0 bought by 105 investors
Millennium Management LLCNomura Asset Management International Inc. +103 more
$0 sold by 74 investors
Ensign Peak Advisors, IncMoore Capital Management, LP +72 more
Bought Sold Totals per quarter; hover a bar for the names.

Phathom Pharmaceuticals, Inc. (PHAT) institutional activity · 74

Investor Type Est. change Change Δ Own Date
Ensign Peak Advisors, Inc · Reduced
Change −724K Date Q1 2026
Ensign Peak Advisors, Inc Reduced· Q1 2026 −724K Q1 2026
Moore Capital Management, LP · Exited
Change −600K Δ Own −100.0% Date Q1 2026
Moore Capital Management, LP Exited· Q1 2026 −600K −100.0% Q1 2026
Susquehanna International Group, LLP · Reduced
Change −456K Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −456K Q1 2026
Catalio Capital Management, LP · Reduced
Change −451K Date Q1 2026
Catalio Capital Management, LP Reduced· Q1 2026 −451K Q1 2026
Next Century Growth Investors LLC · Exited
Change −394K Δ Own −100.0% Date Q1 2026
Next Century Growth Investors LLC Exited· Q1 2026 −394K −100.0% Q1 2026
Jane Street Group, LLC · Exited
Change −385K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −385K −100.0% Q1 2026
Brevan Howard Capital Management LP · Reduced
Change −182K Date Q1 2026
Brevan Howard Capital Management LP Reduced· Q1 2026 −182K Q1 2026
Caxton Associates LLP · Exited
Change −182K Δ Own −100.0% Date Q1 2026
Caxton Associates LLP Exited· Q1 2026 −182K −100.0% Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −129K Δ Own −49.3% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −129K −49.3% Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −112K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −112K Q1 2026
Group One Trading LLC · Reduced
Change −87K Date Q1 2026
Group One Trading LLC Reduced· Q1 2026 −87K Q1 2026
Hussman Strategic Advisors, Inc. · Reduced
Change −63K Date Q1 2026
Hussman Strategic Advisors, Inc. Reduced· Q1 2026 −63K Q1 2026
Simplify Asset Management Inc. · Reduced
Change −60K Date Q1 2026
Simplify Asset Management Inc. Reduced· Q1 2026 −60K Q1 2026
Barclays PLC · Reduced
Change −60K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −60K Q1 2026
Campbell & Co Investment Adviser LLC · Reduced
Change −53K Date Q1 2026
Campbell & Co Investment Adviser LLC Reduced· Q1 2026 −53K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 74

Famous investor activity in Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals, Inc. (PHAT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Breedlove Robert Charles · Officer Tax withholding or exercise payment (F) -$17K
Price $11.04 Qty -2K Owned 60K ΔOwn −2.5% Trade date Jul 14, 2026 Filed date Jul 16, 2026
Breedlove Robert Charles Officer Tax withholding or exercise payment (F) $11.04 -2K -$17K 60K −2.5% Jul 14, 2026 Jul 16, 2026
Parikh Asit · Director 2 operations 0
Owned 148K Trade date May 22, 2026 Filed date May 27, 2026
Parikh Asit Director 2 operations 0 148K May 22, 2026 May 27, 2026
Parikh Asit · Director Exercise or conversion (M/X/C) $87K
Price $4.95 Qty 18K Owned 52K Trade date May 20, 2026 Filed date May 21, 2026
Parikh Asit Director Exercise or conversion (M/X/C) $4.95 18K $87K 52K May 20, 2026 May 21, 2026
Parikh Asit · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -18K
Owned 0 Trade date May 20, 2026 Filed date May 21, 2026
Parikh Asit Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -18K 0 May 20, 2026 May 21, 2026
Parikh Asit · Director Grant (A) 24K
Owned 35K Trade date May 19, 2026 Filed date May 21, 2026
Parikh Asit Director Grant (A) 24K 35K May 19, 2026 May 21, 2026
Topper James N. · Director Grant (A) 24K
Owned 67K Trade date May 19, 2026 Filed date May 21, 2026
Topper James N. Director Grant (A) 24K 67K May 19, 2026 May 21, 2026
Stenhouse Mark · Director Grant (A) 24K
Owned 54K Trade date May 19, 2026 Filed date May 21, 2026
Stenhouse Mark Director Grant (A) 24K 54K May 19, 2026 May 21, 2026
Fields Heidi · Director Grant (A) 24K
Owned 54K Trade date May 19, 2026 Filed date May 21, 2026
Fields Heidi Director Grant (A) 24K 54K May 19, 2026 May 21, 2026
Cola Michael F. · Director Grant (A) 24K
Owned 64K Trade date May 19, 2026 Filed date May 21, 2026
Cola Michael F. Director Grant (A) 24K 64K May 19, 2026 May 21, 2026
Karbe Frank · Director Grant (A) 24K
Owned 92K Trade date May 19, 2026 Filed date May 21, 2026
Karbe Frank Director Grant (A) 24K 92K May 19, 2026 May 21, 2026
Schroeder Theodore R. · Director Grant (A) 24K
Owned 45K Trade date May 19, 2026 Filed date May 21, 2026
Schroeder Theodore R. Director Grant (A) 24K 45K May 19, 2026 May 21, 2026
Parikh Asit · Director 2 operations 0
Owned 10K Trade date Mar 10, 2026 Filed date Mar 11, 2026
Parikh Asit Director 2 operations 0 10K Mar 10, 2026 Mar 11, 2026
Breedlove Robert Charles · Officer 2 operations -$17K
Price $12.56 Qty -1K Owned 61K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Breedlove Robert Charles Officer 2 operations $12.56 -1K -$17K 61K Feb 27, 2026 Mar 3, 2026
Breedlove Robert Charles · Officer 2 operations 16K
Owned 63K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Breedlove Robert Charles Officer 2 operations 16K 63K Feb 27, 2026 Mar 3, 2026
Cook Anne Marie · Officer Tax withholding or exercise payment (F) -$20K
Price $12.82 Qty -2K Owned 89K Trade date Feb 10, 2026 Filed date Feb 12, 2026
Cook Anne Marie Officer Tax withholding or exercise payment (F) $12.82 -2K -$20K 89K Feb 10, 2026 Feb 12, 2026
15 of 37
15 of 37 Sign in to continue to older insider transactions.

Phathom Pharmaceuticals, Inc. (PHAT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Frazier Life Sciences Ix, L.P. 5.8M
% of shares outstanding 14.9% Filing date Sep 26, 2022
Frazier Life Sciences Ix, L.P. 5.8M 14.9% Sep 26, 2022
Jennison Associates LLC 7.0M
% of shares outstanding 10.4% Filing date Nov 4, 2024
Jennison Associates LLC 7.0M 10.4% Nov 4, 2024
Frazier Life Sciences Public Fund, L.P. 5.8M
% of shares outstanding 8.5% Filing date Aug 22, 2024
Frazier Life Sciences Public Fund, L.P. 5.8M 8.5% Aug 22, 2024
Medicxi Growth I LP 3.7M
% of shares outstanding 6.4% Filing date Jan 26, 2024
Medicxi Growth I LP 3.7M 6.4% Jan 26, 2024
Carlyle Group Inc. 3.5M
% of shares outstanding 6.1% Filing date Feb 12, 2024
Carlyle Group Inc. 3.5M 6.1% Feb 12, 2024
Invesco Ltd. 3.2M
% of shares outstanding 5.5% Filing date Feb 9, 2024
Invesco Ltd. 3.2M 5.5% Feb 9, 2024
Blackrock, Inc. 3.1M
% of shares outstanding 5.2% Filing date Nov 12, 2024
Blackrock, Inc. 3.1M 5.2% Nov 12, 2024
Takeda Pharmaceutical Co Ltd 2.8M
% of shares outstanding 4.8% Filing date Apr 10, 2024
Takeda Pharmaceutical Co Ltd 2.8M 4.8% Apr 10, 2024
8 of 14

Phathom Pharmaceuticals, Inc. (PHAT) ownership FAQ

Who owns PHAT?

179 reporting institutions disclosed PHAT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.